ICR researchers develop blood test to uncover how childhood tumours adapt
It is hoped that the approach will lead to more targeted treatments for childhood cancers
Read More
Tag: ICR
Nature publishes new research on genetic causes of colorectal cancer
In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project
Read More
ICR in research partnership with NeoPhore
Collaboration will further boost its promising pipeline of cancer treating therapies
Read More
Institute of Cancer Research embraces olaparib recommendation
Vital AstraZeneca therapy may transform lives of people with certain breast and prostate cancers
Read More
New pricing models could improve access to innovative cancer drugs
Conclusions made by a group of experts from academia and industry
Read More
Research backs use of liquid biopsy for personalised cancer care
The blood test reliably picks up mutations in breast cancer and matches women to different targeted treatments, researchers said
Read More
Immunotherapies could target aggressive pancreatic cancer, research indicates
Scientists have discovered that hard-to-treat pancreatic cancer hijacks a key immune system response
Read More
New data shows steep rise in people waiting for cancer tests
CR UK data also shows 2.3 million fewer tests have taken place compared to a year ago
Read More
Radiotherapy in fewer doses safe for early breast cancer
10-year study shows lower total dose of radiotherapy delivered in fewer but larger doses is safe
Read More
ICR/Cyclacel scientists discover new cancer drug
Fadraciclib is a dual inhibitor of CDK2 and CDK9
Read More
NICE sticks to Zytiga rejection
Around 4,000 men newly diagnosed with high-risk metastatic hormone-sensitive prostate cancer would have been eligible for treatment with the drug
Read More
Public launch for ICR, CR UK spinout Monte Rosa
The company aims to target cancer with new drugs that take advantage of protein degradation
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
